These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35016115)

  • 21. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
    Tanino T; Al-Dabbagh B; Mengin-Lecreulx D; Bouhss A; Oyama H; Ichikawa S; Matsuda A
    J Med Chem; 2011 Dec; 54(24):8421-39. PubMed ID: 22085339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.
    Mashalidis EH; Lee SY
    J Mol Biol; 2020 Aug; 432(18):4946-4963. PubMed ID: 32199982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muraymycins, novel peptidoglycan biosynthesis inhibitors: synthesis and SAR of their analogues.
    Yamashita A; Norton E; Petersen PJ; Rasmussen BA; Singh G; Yang Y; Mansour TS; Ho DM
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3345-50. PubMed ID: 12951123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Merging Natural Products: Muraymycin-Sansanmycin Hybrid Structures as Novel Scaffolds for Potential Antibacterial Agents.
    Niro G; Weck SC; Ducho C
    Chemistry; 2020 Dec; 26(70):16875-16887. PubMed ID: 32897546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MraY Inhibitors as Novel Antibacterial Agents.
    Dini C
    Curr Top Med Chem; 2005; 5(13):1221-36. PubMed ID: 16305528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-Resistance during Muraymycin Biosynthesis: a Complementary Nucleotidyltransferase and Phosphotransferase with Identical Modification Sites and Distinct Temporal Order.
    Cui Z; Wang XC; Liu X; Lemke A; Koppermann S; Ducho C; Rohr J; Thorson JS; Van Lanen SG
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural requirement of tunicamycin V for MraY inhibition.
    Yamamoto K; Katsuyama A; Ichikawa S
    Bioorg Med Chem; 2019 Apr; 27(8):1714-1719. PubMed ID: 30850266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
    Kwak SH; Lim WY; Hao A; Mashalidis EH; Kwon DY; Jeong P; Kim MJ; Lee SY; Hong J
    Eur J Med Chem; 2021 Apr; 215():113272. PubMed ID: 33607457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics.
    Koppermann S; Cui Z; Fischer PD; Wang X; Ludwig J; Thorson JS; Van Lanen SG; Ducho C
    ChemMedChem; 2018 Apr; 13(8):779-784. PubMed ID: 29438582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors.
    Mravljak J; Monasson O; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y
    Eur J Med Chem; 2011 May; 46(5):1582-92. PubMed ID: 21377772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of Antibacterial Spectrum of Muraymycins toward Pseudomonas aeruginosa.
    Takeoka Y; Tanino T; Sekiguchi M; Yonezawa S; Sakagami M; Takahashi F; Togame H; Tanaka Y; Takemoto H; Ichikawa S; Matsuda A
    ACS Med Chem Lett; 2014 May; 5(5):556-60. PubMed ID: 24900879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
    Dini C; Collette P; Drochon N; Guillot JC; Lemoine G; Mauvais P; Aszodi J
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1839-43. PubMed ID: 10969981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lead structures for new antibacterials: stereocontrolled synthesis of a bioactive muraymycin analogue.
    Spork AP; Büschleb M; Ries O; Wiegmann D; Boettcher S; Mihalyi A; Bugg TD; Ducho C
    Chemistry; 2014 Nov; 20(47):15292-7. PubMed ID: 25318977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of a MraY selective analogue of tunicamycins.
    Yamamoto K; Sato T; Hikiji Y; Katsuyama A; Matsumaru T; Yakushiji F; Yokota SI; Ichikawa S
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):349-364. PubMed ID: 31566068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbacaprazamycins: Chemically Stable Analogues of the Caprazamycin Nucleoside Antibiotics.
    Ichikawa S; Yamaguchi M; Hsuan LS; Kato Y; Matsuda A
    ACS Infect Dis; 2015 Apr; 1(4):151-6. PubMed ID: 27622529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comprehensive synthetic study of muraymycins toward the development of novel antibacterial agents].
    Tanino T; Ichikawa S; Uotani K; Oyama H; Matsuda A
    Yakugaku Zasshi; 2011 Mar; 131(3):335-46. PubMed ID: 21372526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-throughput, homogeneous, fluorescence resonance energy transfer-based assay for phospho-N-acetylmuramoyl-pentapeptide translocase (MraY).
    Shapiro AB; Jahić H; Gao N; Hajec L; Rivin O
    J Biomol Screen; 2012 Jun; 17(5):662-72. PubMed ID: 22337656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Sub-Micromolar MraY
    Oliver M; Le Corre L; Poinsot M; Bosco M; Wan H; Amoroso A; Joris B; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of capuramycin and its analogues via a Ferrier-type I reaction and their biological evaluation.
    Kusaka S; Yamamoto K; Shinohara M; Minato Y; Ichikawa S
    Bioorg Med Chem; 2022 Nov; 73():117011. PubMed ID: 36191548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.
    Bugg TD; Rodolis MT; Mihalyi A; Jamshidi S
    Bioorg Med Chem; 2016 Dec; 24(24):6340-6347. PubMed ID: 27021004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.